You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 40 No. 5, May 1983 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL ARTICLES
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Multiple Hormonal Responses to Protirelin (TRH) in Depressed Patients

Andrew Winokur, MD, PhD; Jay D. Amsterdam, MD; Jacqueline Oler, PhD; Joe Mendels, MD; Peter J. Snyder, MD; Stanley N. Caroff, MD; David J. Brunswick, PhD

Arch Gen Psychiatry. 1983;40(5):525-531.


Abstract

• The effects of protirelin (thyrotropin-releasing hormone [TRH]) administration on the release of five pituitary hormones (thyrotropin [TSH], prolactin [Prol], growth hormone, luteinizing hormone, and follicle-stimulating hormone [FSH]) were examined in 45 patients with major depressive disorder and 32 healthy volunteers. Although mean pituitary responses to protirelin in depressed patients and controls appeared to be comparable, depressed patients had higher SDs in all cases. Twelve patients (26.7%) but no controls had two or more abnormal hormonal responses to protirelin administration. The use of several nonparametric analyses revealed significant differences in patterns of hormonal response between depressed patients and controls for TSH, Prol, and FSH. These findings support the hypothesis that increased variability of neuroendocrine responsiveness represents a fundamental aspect of physiologic function in patients with endogenous depression.



Author Affiliations

From the Departments of Psychiatry (Drs Winokur, Amsterdam, Caroff, and Brunswick), Pharmacology (Dr Winokur), Research Medicine (Dr Oler), and Medicine (Dr Snyder), University of Pennsylvania, the Neuropsychopharmacology Unit, Philadelphia Veterans Administration Hospital (Dr Brunswick), and the Institute for the Study of Human Issues (Dr Mendels), Philadelphia.


Footnotes

Accepted for publication Jan 11, 1983.

Reprint requests to Department of Psychiatry G-1, University of Pennsylvania, Philadelphia, PA 19104 (Dr Winokur).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Low Levels of Transthyretin in the CSF of Depressed Patients
Sullivan et al.
Am. J. Psychiatry 1999;156:710-715.
ABSTRACT | FULL TEXT  

Dose-Response Studies With Protirelin
Garbutt et al.
Arch Gen Psychiatry 1994;51:875-883.
ABSTRACT  

Treatment-resistant depression: additional perspectives
Rosenzweig and Amsterdam
J Psychopharmacol 1992;6:167-171.
ABSTRACT  

Endocrine, Cardiovascular, and Behavioral Effects of Intravenous Protirelin in Patients With Panic Disorder
Stein and Uhde
Arch Gen Psychiatry 1991;48:148-156.
ABSTRACT  

The 24-Hour Profile of Plasma Prolactin in Men With Major Endogenous Depressive Illness
Linkowski et al.
Arch Gen Psychiatry 1989;46:813-819.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1983 American Medical Association. All Rights Reserved.